3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Carcinoma, Renal Cell
86
Kidney Neoplasms
25
Neoplasms
24
Breast Neoplasms
18
Gastrointestinal Stromal Tumors
17
Neoplasm Metastasis
15
Carcinoma, Non-Small-Cell Lung
15
Prostatic Neoplasms
8
Urinary Bladder Neoplasms
7
Brain Neoplasms
7
Pancreatic Neoplasms
6
Lung Neoplasms
6
Colorectal Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Solid Tumors
5
Small Cell Lung Carcinoma
5
Ovarian Neoplasms
5
Neuroendocrine Tumors
5
Melanoma
5
Glioblastoma
5
Carcinoma
5
Sarcoma
4
Liver Neoplasms
4
Esophageal Neoplasms
4
Clear-cell metastatic renal cell carcinoma
4
Carcinoma, Hepatocellular
4
Astrocytoma
4
Adenoma, Islet Cell
4
Thyroid Cancer, Papillary
3
Interventions
Cisplatin
7
Mitotane
5
Doxorubicin
5
Etoposide
4
relacorilant
2
Trastuzumab
2
Cytoreduction Surgical Procedures
2
tipifarnib
1
sodium thiosulfate
1
pembrolizumab
1
pegfilgrastim
1
iodophenyl metomidate
1
gossypol acetic acid
1
entinostat
1
cixutumumab
1
avelumab
1
Vincristine
1
Tamoxifen
1
TKM-080301
1
Suramin
1
Sunitinib
1
Streptozocin
1
Radiotherapy
1
Platinum
1
Oxaliplatin
1
Observation
1
N-Ac-CHAVC-NH2
1
N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride
1
Microscopy, Electron
1
Interleukin-12 Subunit p35
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Adrenocortical Carcinoma
×
Sunitinib
×
Clear all
NCT00453895
2019-01-31
SIRAC
University of Wuerzburg
Phase 2
Completed
39 enrolled
10 charts